Literature DB >> 23125331

Plasmacytoid dendritic cells have a cytokine-producing capacity to enhance ICOS ligand-mediated IL-10 production during T-cell priming.

Makoto Ogata1, Tomoki Ito, Keiko Shimamoto, Takahisa Nakanishi, Naoko Satsutani, Rie Miyamoto, Shosaku Nomura.   

Abstract

Plasmacytoid dendritic cells (pDCs) have the potential to prime CD4(+) T-cells to differentiate into IL-10-producing T regulatory cells through preferential expression of inducible co-stimulatory ligand (ICOS-L). Although pDCs produce cytokines such as type-I IFNs, TNF-α, or IL-6 accompanying up-regulation of ICOS-L expression during activation in response to toll-like receptor (TLR)-ligands or IL-3, the roles of the pDC-derived cytokines in T-cell priming remain largely elusive. Therefore, we investigated the functional involvement of these cytokines in generating IL-10-producing T regulatory cells. We found that either IFN-α or IL-6 enhanced the pDC- or ICOS-L-driven generation of IL-10-producing T-cells from naive CD4(+) T-cells and their regulatory functions. However, IFN-α stimulation in the absence of ICOS-L showed only a marginal tendency to increase the T-cell production of IL-10 and thus pDC-derived type-I IFNs in response to CpG could function together with ICOS-L. In addition, IL-6 functioned to generate IL-10-producing T-cells only on T-cell priming by pDCs activated by IL-3 or under IL-4-mediated T(h)2 conditions. Thus, type-I IFNs and IL-6 act as supplementary factors for the ICOS-L-dependent IL-10-producing T-cell differentiation in pDCs activated along the TLR-dependent and IL-3-dependent pathways, respectively. We also showed that pDC-derived TNF-α induced ICOS-L expression on pDCs in an autocrine manner and that IL-6 promoted ICOS expression on T-cells, contributing to the ICOS/ICOS-L-mediated T-cell response. Our results suggest that the ICOS-L-mediated tolerogenic pDC function in adaptive immunity is backed up by the elaborate cytokine-producing ability of pDCs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23125331     DOI: 10.1093/intimm/dxs103

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  15 in total

1.  A distinct subset of plasmacytoid dendritic cells induces activation and differentiation of B and T lymphocytes.

Authors:  Hong Zhang; Josh D Gregorio; Toru Iwahori; Xiangyue Zhang; Okmi Choi; Lorna L Tolentino; Tyler Prestwood; Yaron Carmi; Edgar G Engleman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-06       Impact factor: 11.205

2.  Human Plasmacytoid Dendritic Cells Elicited Different Responses after Infection with Pathogenic and Nonpathogenic Junin Virus Strains.

Authors:  Soledad Negrotto; Hebe A Mena; Agustin E Ure; Carolina Jaquenod De Giusti; Mariela Bollati-Fogolín; Elba M Vermeulen; Mirta Schattner; Ricardo M Gómez
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

3.  ICOSLG-mediated regulatory T-cell expansion and IL-10 production promote progression of glioblastoma.

Authors:  Ryoichi Iwata; Joo Hyoung Lee; Mikio Hayashi; Umberto Dianzani; Kohei Ofune; Masato Maruyama; Souichi Oe; Tomoki Ito; Tetsuo Hashiba; Kunikazu Yoshimura; Masahiro Nonaka; Yosuke Nakano; Lyse Norian; Ichiro Nakano; Akio Asai
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

4.  Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen.

Authors:  R D Fannin; K Gerrish; S O Sieber; P R Bushel; P B Watkins; R S Paules
Journal:  Clin Pharmacol Ther       Date:  2016-02-22       Impact factor: 6.875

5.  Contribution of Dendritic Cell Subsets to T Cell-Dependent Responses in Mice.

Authors:  Georges Abboud; Ahmed S Elshikha; Nathalie Kanda; Leilani Zeumer-Spataro; Laurence Morel
Journal:  J Immunol       Date:  2022-02-09       Impact factor: 5.422

6.  Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS/ICOS-ligand axis in disease course and resolution.

Authors:  P Sakthivel; J Grunewald; A Eklund; D Bruder; J Wahlström
Journal:  Clin Exp Immunol       Date:  2015-11-24       Impact factor: 4.330

Review 7.  Priming of T follicular helper cells by dendritic cells.

Authors:  André Ballesteros-Tato; Troy D Randall
Journal:  Immunol Cell Biol       Date:  2013-10-22       Impact factor: 5.126

8.  Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity.

Authors:  Leslie Guéry; Stéphanie Hugues
Journal:  Front Immunol       Date:  2013-03-06       Impact factor: 7.561

9.  Differential and Overlapping Immune Programs Regulated by IRF3 and IRF5 in Plasmacytoid Dendritic Cells.

Authors:  Kwan T Chow; Courtney Wilkins; Miwako Narita; Richard Green; Megan Knoll; Yueh-Ming Loo; Michael Gale
Journal:  J Immunol       Date:  2018-10-08       Impact factor: 5.426

Review 10.  The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.

Authors:  Barbara Seliger; Chiara Massa
Journal:  Front Immunol       Date:  2013-12-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.